Related Experiment Video

Updated: Sep 26, 2026

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

Overexpression and functional alterations of the EphA2 tyrosine kinase in cancer

Michael S Kinch1, Kelly Carles-Kinch

  • 1MedImmune, Inc., Gaithersburg, Maryland 20878, USA. kinchm@medimmune.com

Clinical & Experimental Metastasis
|March 26, 2003
PubMed

Insights

Aggressive cancer cells often show altered EphA2 receptor tyrosine kinase signaling, promoting metastasis. Targeting these EphA2 changes offers a potential strategy for treating metastatic cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Cancer progression involves subverted intracellular signaling pathways, particularly tyrosine kinases.
  • The EphA2 receptor tyrosine kinase is frequently overexpressed and altered in aggressive tumor cells.
  • These alterations in EphA2 contribute to the metastatic potential of cancer cells.

Purpose of the Study:

  • To provide an overview of the current understanding of EphA2.
  • To emphasize the differential regulation of EphA2 expression and function.
  • To explore the therapeutic potential of targeting EphA2 in metastatic disease.

Main Methods:

  • Review of recent studies on EphA2.
  • Analysis of EphA2 expression and function in cancer cells.
  • Investigation of differential regulation mechanisms.

Main Results:

  • EphA2 is frequently overexpressed and functionally altered in aggressive tumors.
  • These EphA2 changes are linked to increased metastatic character.
  • Differential regulation of EphA2 expression and function is observed.

Conclusions:

  • Altered EphA2 signaling is a hallmark of aggressive and metastatic cancer.
  • Understanding EphA2 regulation is crucial for therapeutic development.
  • Targeting EphA2 presents a promising strategy for selective cancer therapy.

More Related Videos

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...